May 10 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2016 Mar 31, 2015 Mar 31, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 5.35 5.48 5.08 2.45
(-2.4 pct) (-5.6 pct) (-4.9 pct) (-5.0 pct)
Operating 442 mln 401 mln 460 mln 192 mln
(+10.2 pct) (+26.1 pct) (+4.0 pct) (-10.6 pct)
Recurring 440 mln 392 mln 451 mln 188 mln
(+12.3 pct) (+24.9 pct) (+2.3 pct) (-16.0 pct)
Net 296 mln 230 mln 320 mln 141 mln
(+28.7 pct) (+19.3 pct) (+8.0 pct) (-10.1 pct)
EPS 69.39 yen 51.73 yen 76.55 yen 33.73 yen
Ann Div 12.50 yen 12.50 yen 12.50 yen
-Q2 Div NIL NIL NIL
-Q4 Div 12.50 yen 12.50 yen 12.50 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T
((Tokyo Headline News Desk +813 6441 1812))